talent acquisition

talent acquisition

featured image of Lonza Boosts US Manufacturing with $12B Acquisition!

Lonza Boosts US Manufacturing with $12B Acquisition!

BIOT

🚀 Lonza has acquired Roche's Vacaville site for $1.2 billion, boosting U.S. manufacturing and investing $591 million for upgrades! 🏭✨

featured image of MilliporeSigma Boosts Gene Therapy with $600M Acquisition!

MilliporeSigma Boosts Gene Therapy with $600M Acquisition!

BIOT

MilliporeSigma acquires Mirus Bio for $600 million, boosting viral vector manufacturing and supporting gene therapy advancements! 🚀🔬💡🤝

featured image of Repligen to Boost Bioprocessing with Tantti Acquisition!

Repligen to Boost Bioprocessing with Tantti Acquisition!

BIOT

**Excerpt:** 🌟 Repligen is set to acquire Tantti Laboratory, enhancing purification of biologics with innovative chromatography beads! 🧬📈 Exciting growth ahead! 🔜

featured image of Ligand Pharma Snaps Up Apeiron Biologics for $100M

Ligand Pharma Snaps Up Apeiron Biologics for $100M

BIOT

📢 Ligand Pharma acquires Apeiron Biologics for $100M, invests $4M in invIOs Holding AG, and offers future event-based considerations. 🏢💰🏥🤝📅

featured image of MSD Snatches Eyebiotech Ltd for $3bn Dominates Vision Loss Market

MSD Snatches Eyebiotech Ltd for $3bn Dominates Vision Loss Market

BIOT

💰 US pharma giant MSD acquires Eyebiotech Ltd for up to $3bn, gaining their clinical pipeline of vision loss candidates. 👁️‍🗨️🩺 Unanimously approved by EyeBio Board.

featured image of MilliporeSigma Acquires Mirus Bio for $600 Million Expanding in Gene Therapy Market

MilliporeSigma Acquires Mirus Bio for $600 Million Expanding in Gene Therapy Market

BIOT

MilliporeSigma 💪 powers up with $600M acquisition of Mirus Bio! 📆 Closing in Q3 2024. 😮 CellAndGeneTherapy BiotechNews

featured image of Sino Biological Acquires SignalChem Biotech: Boosting Enzyme Expertise and Expanding Protein Presence!

Sino Biological Acquires SignalChem Biotech: Boosting Enzyme Expertise and Expanding Protein Presence!

BIOT

📢 Sino Biological acquires SignalChem Biotech for $48 million, boosting their enzyme production and research capabilities. 🔬💰

featured image of Biopharma's Data Science Skills Gap: The Key to Unlocking Digital Transformation

Biopharma’s Data Science Skills Gap: The Key to Unlocking Digital Transformation

BIOT

📰 Biopharma's digital transition has revealed a skills gap in data science, particularly in areas like integration, analysis, statistical modeling, and machine learning. 🔍⚙️💡🔧👉